REQUEST A DEMO
Total
USD $0.00
Search more companies

C.I. Laboratorios Improfarme S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: C.I. Laboratorios Improfarme S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

C.I. Laboratorios Improfarme S A S is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on June 02, 2004. 85 (2024) employees currently work for C.I. Laboratorios Improfarme S A S. From the latest financial highlights, C.I. Laboratorios Improfarme S A S reported a net sales revenue increase of 6.78% in 2023. Its total assets decreased by 17.09% over the same period.

Headquarters
Cl 64C No 113-58
Bogota D.C.; Bogota D.C; Postal Code: 0917

Contact Details: Purchase the C.I. Laboratorios Improfarme S A S report to view the information.

Basic Information
Total Employees:
Purchase the C.I. Laboratorios Improfarme S A S report to view the information.
Outstanding Shares:
Purchase the C.I. Laboratorios Improfarme S A S report to view the information.
Incorporation Date:
June 02, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after C.I. Laboratorios Improfarme S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.78%
Total operating revenue
6.78%
Operating profit (EBIT)
72.48%
Total assets
-17.09%
Total equity
-11.37%
Operating Profit Margin (ROS)
3.12%
Quick Ratio
-0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?